CA Stock MarketDetailed Quotes

XRX XORTX Therapeutics Inc

Watchlist

4.800
0.0000.00%

15min DelayMarket Closed Nov 4 16:00 ET

59.00MMarket Cap-13.64P/E (TTM)

XORTX Therapeutics Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 31, 2019

(Q4)Dec 31, 2019

(Q3)Sep 30, 2019

Assets

Current assets

Cash, cash equivalents and short term investments

1,542.86%5.15M

1,082.83%6.04M

192.20%171.27K

74.30%189.09K

215.19%313.39K

257.89%510.96K

-77.46%58.61K

-72.06%108.49K

-Cash and cash equivalents

1,542.86%5.15M

1,082.83%6.04M

192.20%171.27K

74.30%189.09K

215.19%313.39K

257.89%510.96K

-77.46%58.61K

-72.06%108.49K

Receivables

6,552.42%1.85M

-50.88%10.92K

59.92%14.35K

-21.46%16.38K

-41.22%27.8K

-24.51%22.23K

-70.34%8.97K

-25.52%20.85K

-Accounts receivable

----

-25.52%20.85K

-Taxes receivable

-17.85%22.84K

-50.88%10.92K

59.92%14.35K

--16.38K

--27.8K

--22.23K

--8.97K

----

-Other receivables

--1.83M

----

Prepaid assets

-95.61%99.42K

-23.16%1.96M

182.21%1.87M

227.26%2.19M

242.45%2.26M

278.30%2.55M

-3.85%662.82K

2.30%669.21K

Restricted cash

----

--0

--70K

----

Current deferred assets

----

--0

--14.84K

----

Total current assets

172.35%7.1M

159.66%8.02M

152.21%2.06M

199.99%2.4M

222.49%2.61M

264.34%3.09M

-16.78%815.25K

-25.40%798.55K

Non current assets

Net PPE

----

--0

-88.84%49

-72.76%146

-61.51%244

-53.35%341

-47.04%439

Goodwill and other intangible assets

-12.30%236.16K

-14.93%230.26K

-13.98%234.32K

-2.98%268.89K

-3.26%269.29K

-3.34%270.68K

-4.38%272.39K

-3.00%277.14K

-Other intangible assets

-12.30%236.16K

-14.93%230.26K

-13.98%234.32K

-2.98%268.89K

-3.26%269.29K

-3.34%270.68K

-4.38%272.39K

-3.00%277.14K

Total non current assets

-12.35%236.16K

-15.01%230.26K

-14.08%234.32K

-3.11%268.94K

-3.39%269.44K

-3.47%270.93K

-4.50%272.73K

-3.13%277.58K

Total assets

155.05%7.33M

145.57%8.25M

110.52%2.29M

147.60%2.66M

164.53%2.88M

197.71%3.36M

-14.01%1.09M

-20.70%1.08M

Liabilities

Current liabilities

Current debt and capital lease obligation

----

--52.83K

--50.81K

----

-Current debt

----

--52.83K

--50.81K

----

Payables

29.39%359.1K

-94.88%25.96K

-35.79%389.98K

-32.25%357.7K

-41.65%277.53K

25.18%507.16K

46.45%607.39K

31.57%527.99K

-accounts payable

29.39%359.1K

-94.88%25.96K

-35.79%389.98K

-32.25%357.7K

-41.65%277.53K

25.18%507.16K

46.45%607.39K

31.57%527.99K

Current accrued expenses

-87.36%62.09K

0.03%503.75K

18.41%644.23K

7.20%536.77K

10.23%491.12K

21.25%503.61K

41.91%544.09K

40.26%500.72K

Current provisions

----

0.72%100.04K

4.13%102.21K

6.17%106.4K

-4.79%97.41K

2.30%99.32K

Other current liabilities

--3.59M

--4.25M

----

Current liabilities

360.83%4.01M

308.27%4.78M

-20.43%1.03M

-11.84%994.51K

-14.56%870.86K

27.07%1.17M

44.34%1.3M

25.80%1.13M

Non current liabilities

Long term debt and capital lease obligation

----

--48.91K

-Long term debt

----

--48.91K

Total non current liabilities

--0

--48.91K

Total liabilities

360.83%4.01M

308.27%4.78M

-20.43%1.03M

-15.50%994.51K

-18.33%870.86K

21.14%1.17M

37.72%1.3M

31.26%1.18M

Shareholders'equity

Share capital

46.78%12.26M

47.05%12.28M

40.84%8.26M

42.39%8.35M

0.00%5.86M

--5.86M

-common stock

46.78%12.26M

47.05%12.28M

40.84%8.26M

42.39%8.35M

0.00%5.86M

--5.86M

Retained earnings

-45.56%-10.43M

-50.35%-10.21M

-18.93%-8.04M

-15.55%-7.59M

-11.31%-7.17M

-8.12%-6.79M

-10.27%-6.76M

-9.82%-6.57M

Other equity interest

82.21%1.49M

122.61%1.4M

51.66%1.04M

50.68%910.77K

38.09%820.32K

8.71%630.8K

16.42%683.01K

11,519.57%604.45K

Total stockholders'equity

65.64%3.32M

58.60%3.47M

693.35%1.26M

1,756.58%1.67M

9,617.13%2M

1,248.57%2.19M

-165.85%-211.72K

-121.90%-100.81K

Total equity

65.64%3.32M

58.60%3.47M

693.35%1.26M

1,756.58%1.67M

9,617.13%2M

1,248.57%2.19M

-165.85%-211.72K

-121.90%-100.81K

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 31, 2019	(Q4)Dec 31, 2019	(Q3)Sep 30, 2019
Assets
Current assets
Cash, cash equivalents and short term investments	1,542.86%5.15M	1,082.83%6.04M	192.20%171.27K	192.20%171.27K	74.30%189.09K	215.19%313.39K	257.89%510.96K	-77.46%58.61K	-77.46%58.61K	-72.06%108.49K
-Cash and cash equivalents	1,542.86%5.15M	1,082.83%6.04M	192.20%171.27K	192.20%171.27K	74.30%189.09K	215.19%313.39K	257.89%510.96K	-77.46%58.61K	-77.46%58.61K	-72.06%108.49K
Receivables	6,552.42%1.85M	-50.88%10.92K	59.92%14.35K	59.92%14.35K	-21.46%16.38K	-41.22%27.8K	-24.51%22.23K	-70.34%8.97K	-70.34%8.97K	-25.52%20.85K
-Accounts receivable	----	----	----	----	----	----	----	----	----	-25.52%20.85K
-Taxes receivable	-17.85%22.84K	-50.88%10.92K	59.92%14.35K	59.92%14.35K	--16.38K	--27.8K	--22.23K	--8.97K	--8.97K	----
-Other receivables	--1.83M	----	----	----	----	----	----	----	----	----
Prepaid assets	-95.61%99.42K	-23.16%1.96M	182.21%1.87M	182.21%1.87M	227.26%2.19M	242.45%2.26M	278.30%2.55M	-3.85%662.82K	-3.85%662.82K	2.30%669.21K
Restricted cash	----	----	--0	--0	--0	--0	--0	--70K	--70K	----
Current deferred assets	----	----	--0	--0	--0	--0	--0	--14.84K	--14.84K	----
Total current assets	172.35%7.1M	159.66%8.02M	152.21%2.06M	152.21%2.06M	199.99%2.4M	222.49%2.61M	264.34%3.09M	-16.78%815.25K	-16.78%815.25K	-25.40%798.55K
Non current assets
Net PPE	----	----	--0	--0	-88.84%49	-72.76%146	-61.51%244	-53.35%341	-53.35%341	-47.04%439
Goodwill and other intangible assets	-12.30%236.16K	-14.93%230.26K	-13.98%234.32K	-13.98%234.32K	-2.98%268.89K	-3.26%269.29K	-3.34%270.68K	-4.38%272.39K	-4.38%272.39K	-3.00%277.14K
-Other intangible assets	-12.30%236.16K	-14.93%230.26K	-13.98%234.32K	-13.98%234.32K	-2.98%268.89K	-3.26%269.29K	-3.34%270.68K	-4.38%272.39K	-4.38%272.39K	-3.00%277.14K
Total non current assets	-12.35%236.16K	-15.01%230.26K	-14.08%234.32K	-14.08%234.32K	-3.11%268.94K	-3.39%269.44K	-3.47%270.93K	-4.50%272.73K	-4.50%272.73K	-3.13%277.58K
Total assets	155.05%7.33M	145.57%8.25M	110.52%2.29M	110.52%2.29M	147.60%2.66M	164.53%2.88M	197.71%3.36M	-14.01%1.09M	-14.01%1.09M	-20.70%1.08M
Liabilities
Current liabilities
Current debt and capital lease obligation	----	----	----	----	----	----	--52.83K	--50.81K	--50.81K	----
-Current debt	----	----	----	----	----	----	--52.83K	--50.81K	--50.81K	----
Payables	29.39%359.1K	-94.88%25.96K	-35.79%389.98K	-35.79%389.98K	-32.25%357.7K	-41.65%277.53K	25.18%507.16K	46.45%607.39K	46.45%607.39K	31.57%527.99K
-accounts payable	29.39%359.1K	-94.88%25.96K	-35.79%389.98K	-35.79%389.98K	-32.25%357.7K	-41.65%277.53K	25.18%507.16K	46.45%607.39K	46.45%607.39K	31.57%527.99K
Current accrued expenses	-87.36%62.09K	0.03%503.75K	18.41%644.23K	18.41%644.23K	7.20%536.77K	10.23%491.12K	21.25%503.61K	41.91%544.09K	41.91%544.09K	40.26%500.72K
Current provisions	----	----	----	----	0.72%100.04K	4.13%102.21K	6.17%106.4K	-4.79%97.41K	-4.79%97.41K	2.30%99.32K
Other current liabilities	--3.59M	--4.25M	----	----	----	----	----	----	----	----
Current liabilities	360.83%4.01M	308.27%4.78M	-20.43%1.03M	-20.43%1.03M	-11.84%994.51K	-14.56%870.86K	27.07%1.17M	44.34%1.3M	44.34%1.3M	25.80%1.13M
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	----	----	----	----	----	--48.91K
-Long term debt	----	----	----	----	----	----	----	----	----	--48.91K
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--48.91K
Total liabilities	360.83%4.01M	308.27%4.78M	-20.43%1.03M	-20.43%1.03M	-15.50%994.51K	-18.33%870.86K	21.14%1.17M	37.72%1.3M	37.72%1.3M	31.26%1.18M
Shareholders'equity
Share capital	46.78%12.26M	47.05%12.28M	40.84%8.26M	40.84%8.26M	42.39%8.35M	42.39%8.35M	42.39%8.35M	0.00%5.86M	0.00%5.86M	--5.86M
-common stock	46.78%12.26M	47.05%12.28M	40.84%8.26M	40.84%8.26M	42.39%8.35M	42.39%8.35M	42.39%8.35M	0.00%5.86M	0.00%5.86M	--5.86M
Retained earnings	-45.56%-10.43M	-50.35%-10.21M	-18.93%-8.04M	-18.93%-8.04M	-15.55%-7.59M	-11.31%-7.17M	-8.12%-6.79M	-10.27%-6.76M	-10.27%-6.76M	-9.82%-6.57M
Other equity interest	82.21%1.49M	122.61%1.4M	51.66%1.04M	51.66%1.04M	50.68%910.77K	38.09%820.32K	8.71%630.8K	16.42%683.01K	16.42%683.01K	11,519.57%604.45K
Total stockholders'equity	65.64%3.32M	58.60%3.47M	693.35%1.26M	693.35%1.26M	1,756.58%1.67M	9,617.13%2M	1,248.57%2.19M	-165.85%-211.72K	-165.85%-211.72K	-121.90%-100.81K
Total equity	65.64%3.32M	58.60%3.47M	693.35%1.26M	693.35%1.26M	1,756.58%1.67M	9,617.13%2M	1,248.57%2.19M	-165.85%-211.72K	-165.85%-211.72K	-121.90%-100.81K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

XRX XORTX Therapeutics Inc

XORTX Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow